Long-Term Outcomes in Patients With Spontaneous Cerebellar Hemorrhage: An International Cohort Study-Reference-Cited by-同舟云学术

Long-Term Outcomes in Patients With Spontaneous Cerebellar Hemorrhage: An International Cohort Study

Published:2024-05 Issue:5 Volume:55 Page:1210-1217
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Senff Jasper R.¹²³⁴⁵^ORCID,Singh Sanjula D.¹²⁶³⁴^ORCID,Pasi Marco⁶⁷⁸^ORCID,Jolink Wilmar M.T.⁹^ORCID,Rodrigues Mark A.¹⁰¹¹^ORCID,Schreuder Floris H.B.M.¹²^ORCID,Staals Julie¹³^ORCID,Schreuder Tobien¹⁴^ORCID,Douwes Jules P.J.¹^ORCID,Talsma Jelmer¹^ORCID,McKaig Brenna N.¹⁵^ORCID,Kourkoulis Christina²³⁴⁵^ORCID,Yechoor Nirupama²³⁴⁵^ORCID,Anderson Christopher D.²⁴⁵¹⁶^ORCID,Puy Laurent⁷^ORCID,Cordonnier Charlotte⁷^ORCID,Wermer Marieke J.H.¹⁷^ORCID,Rothwell Peter M.¹⁸^ORCID,Rosand Jonathan²³⁴⁵^ORCID,Klijn Catharina J.M.¹²^ORCID,Al-Shahi Salman Rustam¹⁰^ORCID,Rinkel Gabriël J.E.¹^ORCID,Viswanathan Anand⁶^ORCID,Goldstein Joshua N.¹⁵^ORCID,Brouwers H. Bart¹¹⁹^ORCID

Affiliation:

1. Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, the Netherlands (J.R.S., S.D.S., J.P.J.D., J.T., G.J.E.R., H.B.B.).

2. Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston (J.R.S., S.D.S., C.K., N.Y., C.D.A., J.R.).

3. Department of Neurology (J.R.S., S.D.S., C.K., N.Y., J.R.), Massachusetts General Hospital, Boston.

4. Center for Genomic Medicine (J.R.S., C.K., N.Y., C.D.A., S.D.S., J.R.), Massachusetts General Hospital, Boston.

5. Broad Institute, Cambridge (J.R.S., S.D.S., J.R.S., C.K., N.Y., C.D.A., J.R.).

6. JPK Stroke Center (S.D.S., M.P., A.V.), Massachusetts General Hospital Stroke Research Center, Harvard Medical School, Boston.

7. University Lille, Inserm, CHU Lille, U1172 – LilNCog – Lille Neuroscience & Cognition, France (M.P., L.P., C.C.).

8. Neurology Department, University Hospital of Tours, INSERM U1253 iBrain, France (M.P.).

9. Department of Neurology, Isala Hospital, Zwolle, the Netherlands (W.M.T.J.).

10. Centre for Clinical Brain Sciences, The University of Edinburgh, United Kingdom (M.A.R., R.A.-S.S.).

11. Department of Neuroradiology, NHS Lothian, United Kingdom (M.A.R.).

12. Department of Neurology, Donders Institute for Brain Cognition & Behavior, Radboud University Medical Center, Nijmegen, the Netherlands (F.H.B.M.S., C.J.M.K.).

13. Department of Neurology and School for Cardiovascular Diseases (CARIM), Maastricht University Medical Center, the Netherlands (J.S.).

14. Department of Neurology, Zuyderland Medical Center, Heerlen, the Netherlands (T.S.).

15. Department of Emergency Medicine (B.N.M., J.N.G.), Massachusetts General Hospital Stroke Research Center, Harvard Medical School, Boston.

16. Department of Neurology, Brigham and Women’s Hospital, Boston (C.D.A.).

17. Department of Neurology, LUMC, Leiden, the Netherlands (M.J.H.W.).

18. Wolfson Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom (P.M.R.).

19. Department of Neurosurgery, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands (H.B.B.).

Abstract

BACKGROUND: Spontaneous intracerebral hemorrhage (ICH) in the cerebellum has a poor short-term prognosis, whereas data on the long-term case fatality and recurrent vascular events are sparse. Herewith, we aimed to assess the long-term case fatality and recurrence rate of vascular events after a first cerebellar ICH. METHODS: In this international cohort study, we included patients from 10 hospitals (the United States and Europe from 1997 to 2017) aged ≥18 years with a first spontaneous cerebellar ICH who were discharged alive. Data on long-term case fatality and recurrence of vascular events (recurrent ICH [supratentoria or infratentorial], ischemic stroke, myocardial infarction, or major vascular surgery) were collected for survival analysis and absolute event rate calculation. RESULTS: We included 405 patients with cerebellar ICH (mean age [SD], 72 [13] years, 49% female). The median survival time was 67 months (interquartile range, 23–100 months), with a cumulative survival rate of 34% at 10-year follow-up (median follow-up time per center ranged: 15–80 months). In the 347 patients with data on vascular events 92 events occurred in 78 patients, after initial cerebellar ICH: 31 (8.9%) patients had a recurrent ICH (absolute event rate, 1.8 per 100 patient-years [95% CI, 1.2–2.6]), 39 (11%) had an ischemic stroke (absolute event rate, 2.3 [95% CI, 1.6–3.2]), 13 (3.7%) had a myocardial infarction (absolute event rate, 0.8 [95% CI, 0.4–1.3]), and 5 (1.4%) underwent major vascular surgery (absolute event rate, 0.3 [95% CI, 0.1–0.7]). The median time to a first vascular event during follow-up was 27 months (interquartile range, 8.7–50 months), with a cumulative hazard of 47% at 10 years. CONCLUSIONS: The long-term prognosis of patients who survive a first spontaneous cerebellar ICH is poor and comparable to that of patients who survive a first supratentorial ICH. Further identification of patients at high risk of vascular events following the initial cerebellar ICH is needed. Including patients with cerebellar ICH in randomized controlled trials on secondary prevention of patients with ICH is warranted.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference40 articles.

1. Intracerebral haemorrhage

2. Racial Variations in Location and Risk of Intracerebral Hemorrhage

3. Long-term mortality after intracerebral hemorrhage

4. Cerebellar Hematoma Location

5. Treatment of intracerebellar haemorrhage: Poor outcome and high long-term mortality

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Extubation Success Prediction Model for Mechanically Ventilated Patients with Spontaneous Cerebellar Hemorrhage;The Cerebellum;2024-09-02

2. Letter to the editor. “Surgical evacuation of spontaneous cerebellar hemorrhage: Comparison of safety and efficacy of suboccipital craniotomy and robotic-assisted stereotactic hematoma drainage”;Clinical Neurology and Neurosurgery;2024-08